| ￥1200 | |
| A05428-50 | |
|
|
|
|
|
|
|
|
|
| Specificity | This product is specific to Condensin complex subunit 1 |
| Host Species | Rabbit |
| Immunogen | A synthesized peptide derived from human Condensin complex subunit 1 |
| Species Reactivity | Human |
| Conjugate | Unconjugated |
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||
|
|||||
| Form | Liquid |
| Storage Buffer | Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Storage Instructions | Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. |
| Purification | Affinity-chromatography |
| Isotype | Rabbit IgG |
| Clonality | Monoclonal |
Western blot analysis of CNAP1 expression in HeLa cell lysate. »
| Target Background | Regulatory subunit of the condensin complex, a complex required for conversion of interphase chromatin into mitotic-like condense chromosomes. The condensin complex probably introduces positive supercoils into relaxed DNA in the presence of type I topoisomerases and converts nicked DNA into positive knotted forms in the. presence of type II topoisomerases. May target the condensin complex to DNA via its C-terminal domain |
| Synonyms | CAPD2; CEP2; CEP250; CNAP1; CND1; Condensin; hCAPD2; NCAPD2; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
